Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Praxis Bioresearch
AddedFeb 17, 2024
UpdatedJun 18, 2026
Praxis Bioresearch

Praxis Bioresearch

Seed

Praxis Biosresearch: Innovating neuropsychiatric treatment with novel prodrug stimulants.

HQ
Sacramento, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Praxis Bioresearch, founded as a privately-held biopharmaceutical company, is dedicated to discovering and developing innovative therapies for chronic neuropsychiatric and neurodegenerative disorders. Their core mission is to translate biological insights into effective treatments, with a vision to improve patient outcomes in these challenging medical areas. The company's primary product, PRX-P4-003, is a novel prodrug stimulant designed to deliver the therapeutic benefits of existing stimulants while reducing the risk of intravenous abuse.

Notable affiliated individuals include experienced professionals in the biopharmaceutical industry, though specific names are not provided. Praxis Bioresearch has garnered attention for its pioneering approach to neuropsychiatric treatment, particularly with PRX-P4-003. This lead candidate has the potential to significantly impact the market by offering safer stimulant options for patients. The company's innovative focus and promising pipeline underscore its growing influence in the biopharmaceutical sector.

Praxis Bioresearch - Similar Companies

Proniras logo

Proniras

proniras.com

Praeventix logo

Praeventix

praeventix.com

Privo Technologies logo

Privo Technologies

Praesidia Biologics logo

Praesidia Biologics

Microbion logo

Microbion

microbioncorp.com

Prexa Pharmaceuticals logo

Prexa Pharmaceuticals

Reset Pharmaceuticals logo

Reset Pharmaceuticals

Primal Therapies logo

Primal Therapies

Therapyx logo

Therapyx

therapyxinc.com

PleoPharma logo

PleoPharma

pleopharma.com

Pranax logo

Pranax

pranax.com

Proterixbio logo

Proterixbio

PhagePro logo

PhagePro

phageproinc.com

Praetego logo

Praetego

praetego.com

ProJenX logo

ProJenX

projenx.com

Praxis Bioresearch - Quick Facts

Who are Praxis Bioresearch's competitors?

Companies similar to Praxis Bioresearch include Proniras, Praeventix, Privo Technologies and Praesidia Biologics.

When was Praxis Bioresearch founded?

Praxis Bioresearch was founded in 2014.

Where is Praxis Bioresearch's headquarters located?

Praxis Bioresearch's headquarters is located in Sacramento, CA, US.

When was Praxis Bioresearch's last funding round?

Praxis Bioresearch's most recent funding round was for $2.9M (USD) in August 2021.

How much has Praxis Bioresearch raised to-date?

As of Aug 5, 2021, Praxis Bioresearch has raised a total of $2.9M (USD).

How many employees does Praxis Bioresearch have?

Praxis Bioresearch has 5 employees as of Feb 4, 2024.

Praxis Bioresearch - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research